V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010311 | 270006038 | 1.8 | 69.4 | Curative (C) | 2014-11-15 | 2014-11-18 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270024285 | DHAP - R |
| 270010312 | 270006039 | 1.75 | 82 | null | 2016-05-21 | 2016-05-21 | ESHAP | 1 | N | 270024287 | NOT MATCHED |
| 270010313 | 270006040 | 1.6 | 48 | Curative (C) | 2017-12-15 | 2018-01-12 | ECHELON-1 TRIAL | N | null | 270024298 | DHAP - R |
| 270010314 | 270006040 | 1.76 | 62.9 | Disease modification (D) | 2016-12-27 | 2016-12-31 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 270024298 | CVP R |
| 270010315 | 270006041 | 1.71 | 102 | Palliative (P) | 2015-04-26 | 2015-04-30 | Rituximab | 2 | N | 270024306 | ENZALUTAMIDE |
| 270010316 | 270006042 | 1.52 | 92.6 | Curative (C) | 2017-10-24 | 2017-11-18 | ECHELON 1 TRIAL | N | null | 270024314 | ETOPOSIDE |
| 270010317 | 270006043 | 1.79 | 77 | Curative (C) | 2015-01-24 | 2015-01-27 | CHLORAMBUCIL + RITUXIMAB | N | N | 270024329 | ECHELON 1 TRIAL |
| 270010318 | 270006044 | 1.68 | 112.3 | Palliative (P) | 2017-09-08 | 2017-09-09 | Brentuximab | 2 | N | 270024340 | RITUXIMAB |
| 270010319 | 270006045 | 1.57 | 71.8 | Curative (C) | 2017-10-22 | 2017-10-31 | CVP R | 02 | N | 270024353 | CVP R |
| 270010320 | 270006046 | null | 93.8 | null | 2015-12-15 | 2016-01-06 | Vinblastine | N | N | 270024360 | GEMCITABINE + PACLITAXEL |
| 270010321 | 270006047 | 1.75 | 59.6 | Palliative (P) | 2016-11-29 | 2016-12-03 | Brentuximab | 02 | N | 270024368 | CHOP |
| 270010322 | 270006048 | null | 68.2 | null | null | 2017-10-30 | CVP R | null | null | 270024400 | AZACITIDINE |
| 270010323 | 270006049 | 1.84 | null | Disease modification (D) | 2014-04-27 | 2014-05-02 | CVP R | N | N | 270024405 | ECHELON-2 TRIAL |
| 270010324 | 270006050 | 1.73 | 84.9 | Adjuvant (A) | 2018-05-19 | 2018-06-03 | BEAM + Alemtuzumab Allo SCT | N | N | 270024435 | CHLVPP/EVA |
| 270010325 | 270006051 | 1.52 | 78.9 | Palliative (P) | 2014-03-07 | 2014-03-18 | IVE | 02 | N | 270024443 | ABVD R |
| 270010326 | 270006052 | 1.73 | null | Curative (C) | 2016-05-09 | 2016-05-12 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | null | 270024445 | CARBOPLATIN + ETOPOSIDE |
| 270010327 | 270006053 | 1.74 | 60.7 | Curative (C) | 2014-09-14 | 2014-09-28 | GEM-P | 02 | N | 270024452 | RITUXIMAB |
| 270010328 | 270006054 | 1.71 | 56 | Curative (C) | 2015-07-01 | 2015-07-12 | CYCLO + RITUXIMAB + VINCRISTINE | 01 | N | 270024455 | CVP |
| 270010329 | 270006054 | 1.78 | 69 | Curative (C) | 2015-02-12 | 2015-02-15 | CHOP - 21 days | N | N | 270024455 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270010330 | 270006054 | 1.58 | null | Curative (C) | 2016-07-14 | 2016-08-10 | null | N | N | 270024455 | CHOP |
| 270010331 | 270017885 | 1.66 | 89.9 | null | 2014-03-26 | 2014-03-31 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270024461 | ABVD R |
| 270010332 | 270006055 | 1.7 | 52 | null | 2016-09-10 | 2016-09-12 | NHL 2003 Gp C COPADM 1 | 02 | N | 270024463 | VINBLASTINE |
| 270010333 | 270006055 | null | 77 | Adjuvant (A) | 2013-10-30 | 2013-11-08 | CHLVPP/EVA | 99 | null | 270024463 | CVP R |
| 270010334 | 270006055 | 1.71 | 69 | Curative (C) | 2017-02-22 | 2017-02-23 | R ABVD | 02 | N | 270024463 | CHOP |
| 270010335 | 270006056 | 1.76 | 65.4 | Curative (C) | 2013-06-11 | 2013-06-13 | R ABVD | N | N | 270024482 | CISPLATIN + ETOPOSIDE |
| 270010336 | 270006057 | null | 59.6 | Curative (C) | 2013-07-19 | 2013-07-27 | BREVITY TRIAL | N | N | 270024485 | CVP R |
| 270010337 | 270006058 | null | null | Curative (C) | 2013-11-02 | 2013-11-28 | AXITINIB | N | N | 270024487 | ECHELON 1 TRIAL |
| 270010338 | 270006059 | 1.75 | 73.3 | Curative (C) | 2015-05-17 | 2015-06-18 | CETUXIMAB + RT | 02 | N | 270024501 | CHOP |
| 270010339 | 270006060 | 1.66 | 78 | null | 2017-06-27 | 2017-06-27 | ECHELON 1 TRIAL | N | N | 270024510 | DHAP - R |
| 270010340 | 270006061 | 1.78 | 64 | Curative (C) | 2013-03-18 | 2013-04-13 | CHOP | null | null | 270024518 | CVP R |
| 270010341 | 270006062 | 1.8 | 92.2 | Disease modification (D) | 2018-05-30 | 2018-06-10 | CVP | 2 | N | 270024533 | NOT MATCHED |
| 270010342 | 270006063 | 1.73 | 98.1 | Curative (C) | 2014-12-31 | 2015-01-05 | R GCVP | N | N | 270024537 | ABVD R |
| 270010343 | 270006064 | 1.63 | 76 | Palliative (P) | 2017-01-21 | 2017-02-18 | ECHELON 1 TRIAL | 02 | N | 270024538 | CYTARABINE HIGH DOSE |
| 270010344 | 270006065 | null | 90.3 | Curative (C) | null | 2017-11-13 | R ABVD | null | null | 270024540 | VINBLASTINE |
| 270010345 | 270006066 | 1.74 | 79.2 | null | 2017-01-18 | 2017-01-24 | BEAM + FLUDARABINE | 02 | N | 270024541 | CHOP |
| 270010346 | 270006067 | 1.65 | 105 | Curative (C) | 2014-02-04 | 2014-02-24 | Rituximab | 02 | N | 270024557 | RITUXIMAB |
| 270010347 | 270006067 | 1.63 | 90.4 | Curative (C) | null | 2014-03-14 | CVP R | N | Y | 270024557 | ABVD R |
| 270010348 | 270006068 | 1.59 | 83.4 | Disease modification (D) | 2013-11-17 | 2013-11-17 | Rituximab | 02 | N | 270024564 | CHOP |
| 270010349 | 270006069 | 1.57 | 70.6 | Not known (9) | 2014-05-09 | 2014-05-30 | BREVITY TRIAL | N | N | 270024586 | BRENTUXIMAB |
| 270010350 | 270012983 | null | 46 | Curative (C) | 2015-01-21 | 2015-01-22 | FLAG + Idarubicin | N | N | 270024596 | NOT MATCHED |
| 270010351 | 270016109 | null | 59.7 | null | 2015-08-27 | 2015-09-04 | CHLORAMBUCIL + RITUXIMAB | 02 | null | 270024605 | CHLORAMBUCIL + VINBLASTINE |
| 270010352 | 270006070 | 1.63 | 76 | Curative (C) | 2014-02-15 | 2014-03-16 | BEAM + Alemtuzumab Allo SCT | N | N | 270024608 | CVP R |
| 270010353 | 270006071 | 1.66 | null | Curative (C) | 2015-02-26 | 2015-02-27 | CVP | N | N | 270024611 | LOPP |
| 270010354 | 270006072 | 1.7 | 66 | Palliative (P) | 2015-08-08 | 2015-08-08 | null | 02 | N | 270024614 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010355 | 270006073 | null | null | Disease modification (D) | 2015-04-08 | 2015-04-15 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270024625 | DHAP - R |
| 270010356 | 270006074 | 1.63 | 53.3 | Curative (C) | null | 2017-05-22 | ChIVPP/EVA | null | null | 270024627 | RITUXIMAB |
| 270010357 | 270006075 | 1.52 | 62.4 | Palliative (P) | 2015-07-05 | 2015-07-05 | Rituximab | N | N | 270024646 | CVP R |
| 270010358 | 270006076 | 1.66 | 86.8 | Disease modification (D) | 2015-02-13 | 2015-02-16 | DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 02 | N | 270024651 | GEMCITABINE + PACLITAXEL |
| 270010359 | 270006077 | 1.7 | 82.5 | Curative (C) | null | 2015-11-19 | CVP R | N | N | 270024654 | ESHAP |
| 270010360 | 270006077 | 1.7 | 101.4 | Curative (C) | 2017-07-19 | 2017-08-04 | GDP | 02 | null | 270024654 | NOT MATCHED |